Posted on November 16, 202211/16/22
Case Study: Benchmarking Pathway-Specific Engagement with Health Plans & Organized Providers to Identify Best Practices
Posted on November 3, 202211/3/22
Payer Oncology Access Management in 2022
Posted on September 14, 20229/14/22
Point of Attack: Developing a Targeted Oncology Account Engagement Strategy and Tactical Platform
Posted on July 27, 20227/27/22
Commercialization Strategies in Oncology — The Right Partner Can Reduce Risk and Boost Rewards
Posted on January 26, 20221/26/22
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
Posted on January 14, 20221/14/22
A Partnership Q&A with EVERSANA and Shorla Pharma
Posted on January 11, 20221/11/22
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
Posted on November 2, 202111/2/21
Bio-Europe “Collaboration Close-Up”: Exploring the EVERSANA – Shorla Pharma Partnership
Posted on September 22, 20219/22/21
Getting Treatments to Patients When They Need Them Most: Next Gen Commercialization in Oncology
Posted on July 13, 20217/13/21